Indaba Capital Management, L.P.
- SEC CIK
- 0001524362
- Latest filing
- Aug 5, 2026
The latest 13F from Indaba Capital Management, L.P. covers Q2 2026 (filed Aug 5, 2026) and reports no long positions. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.
What changed in Q2 2026
Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.
- New
- 0
- Added
- 0
- Reduced
- 0
- Sold out
- 0
Top 5 holdings
Share of this quarter's portfolio value
This filing reports no long positions.
Biggest buys
New and added positions, by estimated amount bought
None this quarter.
Largest weight increases
New and added positions, by percentage points of the portfolio gained
None this quarter.
Biggest sells
Reduced and sold-out positions, by estimated amount sold
None this quarter.
Largest weight decreases
Reduced and sold-out positions, by percentage points of the portfolio lost
None this quarter.
Metrics
13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.
- Portfolio value
- $0
- $0 vs. prior quarter
- Positions
- 0
- 0 vs. prior quarter
- Top 10 concentration
- –
- Top 10 as share of value
- Turnover
- –
- No prior quarter to compare
- Average holding period
- –
- Weighted by value
How these are calculated
- Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
- Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
- Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
- Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.
13F filings by quarter
22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.
Peak $932.6M (Q4 2021)
| Quarter | Filed | Positions | Value | Top 3 holdings | Changes | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 5, 2026 | 0 | $0 | – | vs. Q1 2026 | SEC |
| Q1 2026 | May 15, 2026 | 0 | $0 | – | vs. Q4 2025 | SEC |
| Q4 2025 | Feb 17, 2026 | 1 | $33.8M | ONTF | vs. Q3 2025 | SEC |
| Q3 2025 | Nov 14, 2025 | 5 | $60.7M | ONTFIronwood Pharmaceuticals IncBandwidth Inc. | vs. Q2 2025 | SEC |
| Q2 2025 | Aug 14, 2025 | 10 | $135.4M | Bandwidth Inc.Summit Hotel Pptys IncONTF | vs. Q1 2025 | SEC |
| Q1 2025 | May 15, 2025 | 12 | $166.6M | Bandwidth Inc.Summit Hotel Pptys IncONTF | vs. Q4 2024 | SEC |
| Q4 2024 | Feb 14, 2025 | 10 | $207.5M | OBDEBandwidth Inc.ONTF | vs. Q3 2024 | SEC |
| Q3 2024 | Nov 14, 2024 | 9 | $233.7M | EQCEsperion Therapeutics Inc NeBandwidth Inc. | vs. Q2 2024 | SEC |
| Q2 2024 | Aug 14, 2024 | 7 | $154.9M | EQCBandwidth Inc.ONTF | vs. Q1 2024 | SEC |
| Q1 2024 | May 15, 2024 | 7 | $153.2M | Bandwidth Inc.ONTFSNPO | vs. Q4 2023 | SEC |
| Q4 2023 | Feb 14, 2024 | 9 | $174.2M | Fluidigm Corp DelBandwidth Inc.ONTF | vs. Q3 2023 | SEC |
| Q3 2023 | Nov 14, 2023 | 17 | $339.4M | Tabula Rasa HealthCare, Inc.TRHCFluidigm Corp Del | vs. Q2 2023 | SEC |
| Q2 2023 | Aug 14, 2023 | 15 | $295.5M | Tabula Rasa HealthCare, Inc.TRHCFluidigm Corp Del | vs. Q1 2023 | SEC |
| Q1 2023 | May 15, 2023 | 19 | $323.4M | Tabula Rasa HealthCare, Inc.ONTFTRHC | vs. Q4 2022 | SEC |
| Q4 2022 | Feb 14, 2023 | 35 | $516.9M | Tabula Rasa HealthCare, Inc.BNFTONTF | vs. Q3 2022 | SEC |
| Q3 2022 | Nov 14, 2022 | 44 | $650.0M | Tabula Rasa HealthCare, Inc.HRTONTF | vs. Q2 2022 | SEC |
| Q2 2022 | Aug 15, 2022 | 48 | $760.3M | Tabula Rasa HealthCare, Inc.ZENHRT | vs. Q1 2022 | SEC |
| Q1 2022 | May 16, 2022 | 45 | $883.4M | HRTSPLKSplunk Inc | vs. Q4 2021 | SEC |
| Q4 2021 | Feb 14, 2022 | 48 | $932.6M | Ironsource LtdSNPOONTF | vs. Q3 2021 | SEC |
| Q3 2021 | Nov 15, 2021 | 54 | $867.2M | Ironsource LtdFluidigm Corp DelSTGW | vs. Q2 2021 | SEC |
| Q2 2021 | Aug 16, 2021 | 58 | $926.0M | Ironsource LtdFluidigm Corp DelCSOD | vs. Q1 2021 | SEC |
| Q1 2021 | May 17, 2021 | 55 | $795.5M | Fluidigm Corp DelBenefitfocus, Inc.BNFT | – | SEC |
13D and 13G filings
Companies where Indaba Capital Management, L.P. reports owning 5% or more on Schedule 13D or 13G, and its latest filings.
Current stakes of 5% or more
2 companies, largest stake first.
| Company | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| AXDXAccelerate Diagnostics, Inc | 13D/A | 9.90%2.75M shares | – | Jun 20, 20233 filings | Feb 6, 2025 | SEC |
| EQCEQC Liquidating Trust | 13G/A | 7.80%8.40M shares | −1.10 ppfrom 8.90% | Feb 14, 20252 filings | May 15, 2025 | SEC |
Latest filings
41 filings on file made by Indaba Capital Management, L.P. or listing it as a reporting person; the latest 20 are shown.
| Company | Filed (ET) | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| ONTFON24 Inc. | Apr 3, 20265:18 PM ET | 13D/A | 0.00%0 shares | −10.00 ppfrom 10.00%Below 5% | Apr 1, 2026 | SEC |
| ONTFON24 Inc. | Dec 31, 20255:38 PM ET | 13D/A | 10.00%4.24M shares | 0.00 ppfrom 10.00% | Dec 29, 2025 | SEC |
| EQCEQC Liquidating Trust | May 15, 20253:26 PM ET | 13G/A | 7.80%8.40M shares | −1.10 ppfrom 8.90% | Mar 31, 2025 | SEC |
| ONTFON24 Inc. | Mar 19, 20257:04 PM ET | 13D/A | 10.00%4.24M shares | – | Mar 17, 2025 | SEC |
| EQCEQC Liquidating Trust | Feb 14, 20253:32 PM ET | 13G | 8.90%9.55M shares | New | Dec 31, 2024 | SEC |
| AXDXAccelerate Diagnostics, Inc | Feb 6, 20253:10 PM ET | 13D/A | 9.90%2.75M shares | – | Feb 4, 2025 | SEC |
| LABStandard Biotools Inc. | Nov 14, 2024 | 13G/AOld format | – | – | – | SEC |
| AXDXAccelerate Diagnostics, Inc | Aug 12, 2024 | 13D/AOld format | – | – | – | SEC |
| ONTFON24 Inc. | Feb 26, 2024 | 13D/AOld format | – | – | – | SEC |
| LABStandard Biotools Inc. | Feb 14, 2024 | 13G/AOld format | – | – | – | SEC |
| ONTFON24 Inc. | Jan 18, 2024 | 13D/AOld format | – | – | – | SEC |
| TRHCTabula Rasa HealthCare, Inc. | Nov 14, 2023 | 13D/AOld format | – | – | – | SEC |
| TRHCTabula Rasa HealthCare, Inc. | Aug 8, 2023 | 13D/AOld format | – | – | – | SEC |
| AXDXAccelerate Diagnostics, Inc | Jun 20, 2023 | 13DOld format | – | New | – | SEC |
| ONTFON24 Inc. | Mar 13, 2023 | 13D/AOld format | – | – | – | SEC |
| LABStandard Biotools Inc. | Feb 14, 2023 | 13G/AOld format | – | – | – | SEC |
| ONTFON24 Inc. | Dec 20, 2022 | 13DOld format | – | – | – | SEC |
| BNFTBenefitfocus, Inc. | Nov 3, 2022 | 13D/AOld format | – | – | – | SEC |
| TRHCTabula Rasa HealthCare, Inc. | Sep 14, 2022 | 13D/AOld format | – | – | – | SEC |
| TRHCTabula Rasa HealthCare, Inc. | Jul 28, 2022 | 13D/AOld format | – | – | – | SEC |